![Armin W. Mäder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Armin W. Mäder
Fondateur chez Qvanteq AG
Postes actifs de Armin W. Mäder
Sociétés | Poste | Début | Fin |
---|---|---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Directeur Financier/CFO | 04/11/2009 | - | |
Qvanteq AG
![]() Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Président | 01/01/2009 | - |
Fondateur | 01/01/2009 | - |
Historique de carrière de Armin W. Mäder
Anciens postes connus de Armin W. Mäder
Sociétés | Poste | Début | Fin |
---|---|---|---|
AC IMMUNE SA | Directeur des opérations | - | - |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Directeur Général | - | - |
Président | - | - | |
Institut Straumann AG
![]() Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. | Directeur Financier/CFO | - | - |
Formation de Armin W. Mäder
International Institute for Management Development | Masters Business Admin |
Swiss Federal Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Suisse | 8 |
Opérationnelle
Chief Executive Officer | 2 |
Director of Finance/CFO | 2 |
Chairman | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Entreprise privées | 4 |
---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
Institut Straumann AG
![]() Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. | Health Services |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Health Technology |
Qvanteq AG
![]() Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Health Technology |
- Bourse
- Insiders
- Armin W. Mäder
- Expérience